These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7295464)

  • 21. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow.
    Nylund L; Lunell NO; Lewander R; Sarby B; Thornström S
    Acta Obstet Gynecol Scand Suppl; 1984; 118():71-3. PubMed ID: 6587732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine and metabolic effects of labetalol in man.
    Barbieri C; Ferrari C; Caldara R; Crossignani RM; Bertazzoni A
    J Cardiovasc Pharmacol; 1981; 3(5):986-91. PubMed ID: 6168866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):127S-131S. PubMed ID: 7093096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
    Lardoux H; Gerard J; Blazquez G; Chouty F; Flouvat B
    Eur Heart J; 1983 Nov; 4 Suppl G():35-40. PubMed ID: 6662119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which beta-blocker in pregnancy-induced hypertension?
    Lardoux H; Gerard J; Blazquez G; Flouvat B
    Lancet; 1983 Nov; 2(8360):1194. PubMed ID: 6139547
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertensive and catecholamine response to tracheal intubation in patients with pregnancy-induced hypertension.
    Lavies NG; Meiklejohn BH; May AE; Achola KJ; Fell D
    Br J Anaesth; 1989 Oct; 63(4):429-34. PubMed ID: 2818920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
    Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
    Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
    Frick MH; Pörsti P
    Br Med J; 1976 May; 1(6017):1046-8. PubMed ID: 773498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of labetalol in pregnancy.
    Riley AJ
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S53-9. PubMed ID: 6169960
    [No Abstract]   [Full Text] [Related]  

  • 37. Labetalol disposition and concentration-effect relationships during pregnancy.
    Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
    Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diazoxide and labetalol in acute hypertension during haemodialysis.
    Keusch G; Schiffl H; Binswanger U
    Eur J Clin Pharmacol; 1983; 25(4):523-7. PubMed ID: 6653648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
    Ashe RG; Moodley J; Richards AM; Philpott RH
    S Afr Med J; 1987 Mar; 71(6):354-6. PubMed ID: 3551127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.